Testing and interpreting measures of ovarian reserve: a committee opinion
Alan S. Penzias, Ricardo Azziz, Kristin Anne Bendikson et al. · Fertility and Sterility · 2020
Cited by 617 works. doi:10.1016/j.fertnstert.2020.09.134 Open-access PDF
Authors
- Alan S. Penzias
- Ricardo Azziz
- Kristin Anne Bendikson
- Tommaso Falcone
- Karl R. Hansen
- Micah J. Hill
- William W. Hurd
- Sangita Jindal
- Suleena Kansal Kalra
- Jennifer Mersereau
- Catherine Racowsky
- Robert W. Rebar
- Richard Henry Reindollar
- Chevis N. Shannon
- Anne Z. Steiner
- Dale W. Stovall
- Cigdem Tanrikut
- Hugh Stott Taylor
- Belinda J. Yauger
References
- ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria
- Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve
- A systematic review of tests predicting ovarian reserve and IVF outcome
- Antimüllerian hormone serum levels: a putative marker for ovarian aging
- Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles
- Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)
- Executive summary: stages of reproductive aging workshop (STRAW)
- Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve
- Anti-Mullerian Hormone Levels in the Spontaneous Menstrual Cycle Do Not Show Substantial Fluctuation
- Serum anti-Mullerian hormone throughout the human menstrual cycle